This looks very promising to me though I guess that more work will be needed before/if it enters clinical practice.

Nature Nanotechnology is an excellent journal with an impact factor of 39. That means that the average paper in it is cited by 39 other papers every year. It is extremely difficult to get a paper published in it - most manuscripts will be rejected during peer-review. It is most unlikely that poor quality manuscripts would survive peer-review.